NOAC associated bleeding
Posted On February 25, 2020
Time Anticoagulation effect resolved
5 half live since last dose
- Dabigatran (Pradaxa): 2.5 to 3.5 days
- Rivaroxaban (Xarelto): 1-2 days
- Apixaban (Eliquis): 1.5 to 3 days
Management
- Discontinue medication
- Specific reversal agent
- Dabigatran: idarucizumab (Praxbind)
- initial dose 2.5 g iv, repeat in 20 min, total of 5 g
- Apixaban, Rivaroxaban:
- Andexanet alfa (AndexXa): initial dose depends of noac dose and interval since last dose
- or 4 factor PCC (KCentra) 50 units/kg
- Dabigatran: idarucizumab (Praxbind)